Welcome to our dedicated page for Trimas SEC filings (Ticker: TRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how TriMas allocates capital across packaging, aerospace, and specialty products can feel like piecing together three separate 10-Ks. Notes on recent bolt-on acquisitions, segment margins, and backlog shifts are scattered through hundreds of pages, while Form 4 insider buys may hit EDGAR when you least expect them. Stock Titan solves that problem.
Our platform ingests every TriMas filing the moment it posts—whether it is a TriMas quarterly earnings report 10-Q filing, an 8-K announcing a strategic acquisition, or a TriMas proxy statement executive compensation schedule. AI-powered summaries distill the essentials so you can compare Packaging growth versus Aerospace backlog in seconds. Need to gauge management sentiment? Get TriMas Form 4 insider transactions real-time alerts and see TriMas executive stock transactions Form 4 plotted alongside price moves.
Use our expert analysis to:
- Surface key cash-flow trends from the TriMas annual report 10-K simplified
- Spot material event triggers with TriMas 8-K material events explained
- Dive into segment commentary through TriMas earnings report filing analysis
Form 144 filed for TriMas Corporation (TRS) discloses that insider Thomas A. Amato plans to sell 36,705 common shares through Fidelity Brokerage on or about 31 Jul 2025 on Nasdaq. Based on the filing’s stated 40,641,562 shares outstanding, the proposed sale represents roughly 0.09 % of shares outstanding and carries an aggregate market value of ≈ $1.30 million.
The notice also lists recent insider activity: Amato sold 63,965 shares on 29 Jul 2025 for $2.24 million and 95,469 shares on 30 Jul 2025 for $3.39 million, totaling 159,434 shares (≈ 0.39 % of O/S) and ≈ $5.63 million in gross proceeds over the prior three months. All shares being sold were acquired via restricted-stock vesting between 2020-2024 and are treated as compensation, implying no cash outlay by the filer.
No adverse information about the issuer is asserted, and the filer affirms compliance with Rule 10b5-1/Rule 144 representations. While the volume is modest versus the float, consecutive sizeable sales within days could be viewed by investors as a potential negative sentiment signal from senior leadership.
TriMas Corp. (TRS) – Form 144 filing
Insider Thomas A. Amato has notified intent to sell 65,982 common shares through Fidelity on or about 30-Jul-2025 via NASDAQ. The proposed sale is valued at $2.33 million, based on the stated aggregate market value, and equals roughly 0.16 % of the company’s 40.65 million shares outstanding. The shares stem from restricted-stock vesting events between 2021-2023.
The same insider already sold 63,965 shares for $2.24 million on 29-Jul-2025. Form 144 is only a notice of possible sales; transactions may not occur as stated and do not, by themselves, indicate operational issues. No earnings, guidance, or other financial metrics are included in this filing.
Thomas James Snyder, President and CEO of Trimas Corp (TRS), reported significant equity compensation awards on June 24, 2025. The insider received 152,439 shares of common stock as a direct grant and was awarded substantial stock options:
- 100,000 options at $30 strike price
- 200,000 options at $35 strike price
- 200,000 options at $40 strike price
- 200,000 options at $45 strike price
- 200,000 options at $50 strike price
All options expire on June 24, 2035, with vesting occurring in five equal annual installments from 2026 through 2030. The tiered strike price structure suggests a performance-based incentive design, with higher potential rewards tied to stock price appreciation. The total grant of 900,000 option shares represents a significant long-term alignment with shareholder interests.
FAQ
What is the current stock price of Trimas (TRS)?
What is the market cap of Trimas (TRS)?
